AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,386.00p
   
  • Change Today:
    -98.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 1,138,968
  • Market Cap: £161,049m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £91,697,059
Aradhana Sarin 118,367 £12,293,597
Marcus Wallenberg 60,028 £6,234,508
Michel Demare 10,000 £1,038,600
Philip A J Broadley 8,025 £833,476
Tony Mok 3,500 £363,510
Sheri McCoy 1,736 £180,301
Diana Layfield 1,400 £145,404
Karen Knudsen 1,400 £145,404
Euan Ashley 1,150 £119,439
Nazneen Rahman 1,017 £105,626
Anna Manz 487 £50,580

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £10,477,934,899
Oddo Meriten Asset Management SA 100,885,181 £10,477,934,899
The Capital Group Companies, Inc. 77,540,115 £8,053,316,344
Wellington Management Company LLP 65,118,411 £6,763,198,166
Investor AB 51,587,810 £5,357,909,947

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,386.00p
Change Today -98.00p
% Change -0.93 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,138,968
Shares Issued 1,550.64m
Market Cap £161,049m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.62% below the market average93.62% below the market average93.62% below the market average93.62% below the market average93.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
27.73% below the market average27.73% below the market average27.73% below the market average27.73% below the market average27.73% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Income
61.15% below the market average61.15% below the market average61.15% below the market average61.15% below the market average61.15% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average86.41% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 28-May-2025

Time Volume / Share Price
15:08 0 @ 10,426.00p
15:08 0 @ 10,426.00p
15:08 0 @ 10,426.00p
15:08 0 @ 10,426.00p
15:08 0 @ 10,426.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page